GLP-1 receptor agonists are a class of prescription medications that have fundamentally changed what's medically possible for weight loss. The clinical outcomes they produce, 15 to 22 percent average body weight reduction over 68 weeks, are several times better than any previous weight loss medication. Understanding how they work explains why.
What GLP-1 Actually Is
GLP-1 stands for glucagon-like peptide-1. It's a hormone your body produces naturally in the gut after you eat. GLP-1 does several things simultaneously: it signals the pancreas to release insulin, it suppresses glucagon (which would otherwise raise blood sugar), and critically, it signals the brain that you're full. GLP-1 receptor agonists are synthetic versions of this hormone, or molecules that mimic it, that stay active in the body far longer than the natural hormone does.
The natural GLP-1 hormone has a half-life of about 2 minutes. Semaglutide, by contrast, has a half-life of about one week. That's why semaglutide is dosed weekly, one injection maintains therapeutic levels throughout the week.
The Three Main Effects
Appetite suppression: This is the primary mechanism for weight loss. GLP-1 receptors in the brain, specifically in the hypothalamus and brainstem, register the drug and reduce hunger signals. Many patients describe this as "food noise" going quiet. Thoughts about food, cravings, and the compulsive drive to eat diminish significantly.
Slowed gastric emptying: GLP-1 medications slow how quickly food moves from the stomach into the small intestine. Food stays in the stomach longer, which prolongs the feeling of fullness after a meal. This also contributes to the nausea many patients experience, especially at higher doses.
Blood sugar regulation: GLP-1 medications stimulate insulin release in a glucose-dependent manner, meaning they only trigger insulin when blood sugar is elevated. This makes them effective for type 2 diabetes management without the hypoglycemia risk associated with some other diabetes medications.
The Main GLP-1 Medications
Semaglutide (Ozempic, Wegovy, compounded): A GLP-1 receptor agonist approved for type 2 diabetes (Ozempic) and chronic weight management (Wegovy). Compounded semaglutide is the form most accessible through telehealth at $147–200/month. The STEP trials showed average weight loss of 15–20% of body weight over 68 weeks.
Tirzepatide (Mounjaro, Zepbound, compounded): A dual GLP-1/GIP receptor agonist. By activating two receptor pathways instead of one, it tends to produce somewhat stronger effects. SURMOUNT trials showed average weight loss of 20–22% over 72 weeks. Compounded tirzepatide is available through telehealth from about $197/month.
Liraglutide (Saxenda): An older daily-injection GLP-1 medication. Less commonly prescribed for weight loss now given the significantly better outcomes of semaglutide and tirzepatide with weekly dosing.
Who They're For
GLP-1 medications for weight loss are typically prescribed for adults with:
- A BMI of 30 or higher (obesity), or
- A BMI of 27 or higher (overweight) with at least one weight-related health condition such as type 2 diabetes, high blood pressure, or sleep apnea
Physicians evaluate individual cases and may prescribe outside these guidelines based on clinical judgment. They also screen for contraindications, including a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or prior serious reactions to GLP-1 medications.
What GLP-1 Medications Are Not
GLP-1 medications are not a temporary fix. The clinical evidence shows that weight returns when people stop taking them, this is why many people who achieve good outcomes continue taking them long-term. They're also not over-the-counter products. Every legitimate GLP-1 prescription requires evaluation by a licensed physician.